solvent, there is solution containing 10 mg/ml cabazitaxel. The printed package leaflet of the medicinal product must state the name and address of the. See JEVTANA 20 mg/m² recommended dosing and dose modifications (every 3 weeks with prednisone 10 mg daily). 25 mg/m² can be considered in select. Package leaflet: Information for the patient. JEVTANA® 60 mg concentrate and solvent for solution for infusion. cabazitaxel. Read all of this leaflet carefully.
|Published (Last):||19 February 2008|
|PDF File Size:||18.98 Mb|
|ePub File Size:||8.26 Mb|
|Price:||Free* [*Free Regsitration Required]|
Common may affect up to 1 in 10 people: Secondary prophylaxis with G-CSF should be considered in all patients at increased risk for neutropenia complications. Deaths within 30 days of the last study drug dose 5. When your advanced prostate cancer is progressing, plan your next step.
It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged. JEVTANA is used to treat men with castration-resistant prostate cancer prostate cancer that is resistant to medical or surgical treatments that packaeg testosterone that has worsened progressed after treatment with other medicines, including docetaxel.
Insfrt a doctor immediately if you notice any of the following side effects:. If any of the above applies to you, tell your doctor immediately. If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. Please tell your doctor, pharmacist or nurse if you are taking or have recently taken any other medicines. Tell your HCP if you have any side effect that bothers you or that does not go away.
By reporting side effects you can help provide more information on the safety of this medicine.
Adverse Reactions Hematologic Lab Abnormalities. To view the changes to a medicine you must sign up and log in. Your HCP may prescribe treatment for you as needed. Extensive prior radiation ports Poor nutritional status Other serious comorbidities. Sanofi Patient Connection Resources.
Your doctor will discuss these with you and will explain the potential risks and benefits of your treatment. Patients should receive premedication. Tell your doctor immediately if: Febrile neutropenia or neutropenic infection.
Also, tell your HCP if you have any diarrhea during the time that your white blood cell count is low. These medicines include the following:.
Dosing and Dose Modifications. Contents of the pack and other information. Links to product labels will take you to relevant clinical information on the indication, contraindications, dosing, and safety.
One single use clear glass vial, closed with a grey chlorobutyl rubber closure sealed by a gold colour aluminium cap with a colourless plastic flip-off cover, containing 4. Men who are 65 years or older may be more likely to have Show More. The original can be viewed in PDF format using the link above. The most common reasons for dose discontinuation were fatigue and hematuria. Use a condom during sex if your partner is or could become pregnant. The concentrate is a clear yellow to brownish yellow oily solution.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Call your doctor for medical advice about side effects. The solvent is a clear and colourless solution. Tell your HCP if: All of the early infection-related deaths occurred in patients greater than 60 years of age. If you have any further questions, ask your doctor, pharmacist or nurse.
Your HCP will regularly check your red blood cell count. Healthcare Professionals I am a U. You are about to leave jevtanapro.
Cabazitaxel (Jevtana) | – A Hematology Oncology Wiki
Do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vials after EXP. Primary prophylaxis with G-CSF is recommended in patients with high-risk clinical features. For any information about this medicine, pzckage contact the local representative of the Marketing Authorisation Holder:.
Cabaziitaxel dexchlorpheniramine 5 mg or diphenhydramine 25 mg or equivalent antihistamine Corticosteroid dexamethasone 8 mg or equivalent steroid H 2 antagonist ranitidine 50 mg or equivalent H 2 antagonist Antiemetic prophylaxis is recommended and can be given orally or intravenously as needed. How much and how often to have The usual dose depends on your body surface area.